Trulieve to Announce Q3 Earnings on November 19!
Nov. 16 2018, Published 2:32 p.m. ET
A look at Trulieve
Trulieve Cannabis Corp (TCNNF) is a licensed medical cannabis company set to release its Q3 2018 earnings on November 19 at 10:00 AM ET. Below, we outline Wall Street analysts’ estimates for EPS and revenues.
The above chart compares revenues for Trulieve since the first quarter of 2018 and estimates for the third quarter of 2018.
Revenue estimates for Q3 2018
Analysts expect Trulieve to report revenues of 35.1 million Canadian dollars for the third quarter of 2018.
Trulieve is a vertically integrated cannabis company involved in the cultivation, production, and commercialization of cannabis products in the State of Florida. It has 21 dispensaries in Florida, making it one of the largest fully licensed medical cannabis companies in the state.
On November 8, Trulieve announced its acquisition of Life Essence and Leef Industries. Both these acquisitions are subject to regulatory approvals and should help Trulieve expand its territory beyond Florida. Life Essence is a vertically integrated cannabis company with a presence at multiple locations under development in Massachusetts. Leef Industries is a licensed medical and adult-use cannabis dispensary in Palm Springs, California.
Profitability estimates
Wall Street analysts expect the company’s gross profit margin to be around 75.0% during the third quarter of 2018 while the EBITDA margin is estimated at around 49.2%. The company is expected to report adjusted net income of 9.1 million Canadian dollars during the quarter. Its adjusted EPS are forecast at 0.08 Canadian dollars during the third quarter of 2018.
The Horizons Marijuana Life Sciences Index ETF (HMMJ) invests 8.6% of its portfolio in GW Pharmaceuticals (GWPH), 11.7% in Tilray (TLRY), and 11.6% in Canopy Growth (WEED).
